We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current KNSA market cap is 2.11B. The company's latest EPS is USD -0.5919 and P/E is -48.72.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 79.86M | 108.63M | 112.21M | 122.54M | 137.79M |
| Operating Income | -16.54M | -117k | -60.47M | -19.3M | 13.27M |
| Net Income | -17.7M | -3.91M | -12.69M | -8.89M | 8.54M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 38.54M | 220.18M | 270.26M | 423.24M |
| Operating Income | -157.36M | -156.64M | 9.77M | -25.2M | -45.62M |
| Net Income | -161.38M | -157.92M | 183.36M | 14.08M | -43.19M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 519.67M | 542.43M | 555.3M | 580.55M | 599.33M |
| Total Liabilities | 87.78M | 107.33M | 118.29M | 142.12M | 141.84M |
| Total Equity | 431.9M | 435.1M | 437.01M | 438.44M | 457.49M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 349.46M | 232.8M | 459.67M | 526.32M | 580.55M |
| Total Liabilities | 37.53M | 47.76M | 63.52M | 87.48M | 142.12M |
| Total Equity | 311.94M | 185.04M | 396.15M | 438.84M | 438.44M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 3.99M | 9.16M | 6.92M | 25.69M | 22.32M |
| Investing | 25.52M | -21.27M | -27.62M | 37.67M | -51.54M |
| Financing | 3.61M | 3.44M | 10.12M | 12.27M | 2.77M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -136.53M | -126.3M | 5.81M | 13.3M | 25.69M |
| Investing | -23.44M | 128.64M | -8.08M | -29.56M | 37.67M |
| Financing | 227.09M | 5.89M | 2.52M | 1.5M | 12.27M |
| Market Cap | 2.11B |
| Price to Earnings Ratio | -48.72 |
| Price to Sales Ratio | 4.97 |
| Price to Cash Ratio | 11.46 |
| Price to Book Ratio | 4.8 |
| Dividend Yield | - |
| Shares Outstanding | 72.97M |
| Average Volume (1 week) | 703.74k |
| Average Volume (1 Month) | 1.18M |
| 52 Week Change | 42.33% |
| 52 Week High | 30.69 |
| 52 Week Low | 17.82 |
| Spread (Intraday) | 0.02 (0.07%) |
| Company Name | Kiniksa Pharmaceuticals International PLC |
| Address |
third floor london W1S 4PZ |
| Website | https://www.kiniksa.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
